# Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809)

> **NCT05621252** · PHASE2 · COMPLETED · sponsor: **Pliant Therapeutics, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** PLN-74809
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05621252
- **Lead sponsor:** Pliant Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-13
- **Primary completion:** 2023-12-27
- **Final completion:** 2024-01-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05621252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05621252, "Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05621252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*